Life sciences company Thermo Fisher (NYSE: TMO) will be reporting earnings this Thursday before the bell. Here’s what to look for.

Thermo Fisher beat analysts’ revenue expectations last quarter, reporting revenues of $12.22 billion, up 7.2% year on year. It was a strong quarter for the company, with an impressive beat of analysts’ revenue estimates and a narrow beat of analysts’ organic revenue estimates.

Is Thermo Fisher a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.

This quarter, the market is expecting Thermo Fisher’s revenue to grow 4.6% year on year, improving from its flat revenue in the same quarter last year.

The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Thermo Fisher rarely misses Wall Street’s revenue estimates.

With Thermo Fisher being the first among its peers to report earnings this season, we don’t have anywhere else to look to get a hint at how this quarter will unravel for life sciences tools & services stocks. However, there has been positive investor sentiment in the segment, with share prices up 7.5% on average over the last month. Thermo Fisher is up 10% during the same time .

ALSO WORTH WATCHING: Nvidia’s Quiet Partner. Nvidia’s chips cost a hundred grand. The connectors that make them work cost even more. One company makes them all.

Every AI server needs specialized infrastructure the chip companies don’t make. High-speed cables. Power connectors. Thermal sensors. This 90-year-old company built a monopoly on it. The AI boom just started. This stock is still flying under the radar. Claim The Stock Ticker Here for FREE.